The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $310,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund KUMCRI's research project "Discovery of Novel, Early Response Biomarkers for Trials in ADPKD" from September 30, 2023 to April 30, 2025.
As a not-for-profit medical research organization, KUMCRI will use this funding to conduct biomedical research aimed at identifying new biomarkers for early detection of autosomal dominant polycystic kidney disease (ADPKD). The project supports the Military Medical Research and Development program's goals of investigating medical solutions for service members and transforming public health through innovative research. Findings could advance clinical trials and care for those with ADPKD, a genetic disorder affecting kidney function.
Generated 2/20/24, 8:52 AM